Current health economics research that is funded, commissioned or conducted by Macmillan includes:
What explains cancer costs in England?
Mauro Laudicella at City University, London, is examining the magnitude and variations of cancer costs across different stages of the disease, geographical areas and pathways of care. He is analysing data from 1.2 million patients to identify the direct hospital costs and economic costs of four of the most common types of cancer in England: breast, colorectal, prostate and lung cancer.
Read an academic journal article on this research [PDF].
Costing the Recovery Package
Optimity Advisors are conducting a cost consequence analysis to understand the wider economic benefits of the Recovery Package. The Recovery Package helps people living with a diagnosis of cancer to prepare for the future and identify their individual concerns and support needs. It has been adopted by the NHS as a priority intervention. The research project is analysing the cost and benefits of the four central elements of the Recovery Package: Holistic Needs Assessments, Treatment Summaries, Cancer Care Reviews, and Health and Wellbeing Events.
Findings from this study will be available in 2016.
Cancer cash crisis: counting the cost of care beyond treatment
In December 2015, Macmillan published Cancer cash crisis: counting the cost of care beyond treatment. This report explored the cost of long-term care for people with cancer. It brought together analysis from a range of sources including NHS waiting times and budget data, international comparisons of cancer survival, and new findings from three major research studies funded by Macmillan.
Download the Cancer Cash Crisis report [PDF].